cocaine has been researched along with Schizophrenia in 107 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (16.82) | 18.7374 |
1990's | 49 (45.79) | 18.2507 |
2000's | 18 (16.82) | 29.6817 |
2010's | 15 (14.02) | 24.3611 |
2020's | 7 (6.54) | 2.80 |
Authors | Studies |
---|---|
Holwerda, TJ; Yildiz, RLW | 1 |
Chesworth, R; Karl, T; Visini, G | 1 |
Batra, G; Chan, KMY; Guruswamy, G; Ker, S; Kollins, SH; Palmer, EOC; Patel, R; Rentería, ME; Valko, M | 1 |
Ambrosio, E; Borcel, É; Higuera-Matas, A; Santos-Toscano, R; Ucha, M | 1 |
Baquero, A; García-Gallego, A; Georgantzís, N; Haro, G; Herranz-Zarzoso, N; Sabater-Grande, G | 1 |
Childress, AR; Hu, Y; Patti, MA; Regier, PS; Troiani, V; Wochele, S | 1 |
Andrade, YCP; Batista, LA; Del Bel, EA; Fanelli, C; Issy, AC; Liégeois, JF; Minaldi, E; Moreira, FA; Rodrigues, LCM; Ropke, J; Viana, TG | 1 |
Bergman, J; Carlezon, WA; Coyle, JT; Desai, RI; Donahue, RJ; Doyle, MR; Landino, SM; Presti, KT; Puhl, MD; Takagi, S | 1 |
da Silveira, VT; de Oliveira, AC; Del Bel, EA; Issy, AC; Matosinhos, AL; Moreira, FA; Röpke, J | 1 |
Agnati, LF; Borroto-Escuela, DO; Ciruela, F; Fuxe, K; Palkovits, M; Romero-Fernandez, W; Tarakanov, AO | 1 |
Meijer, CJ; Meijer, JH; van den Brink, W; van der Meer, FJ; Velthorst, E | 1 |
Burns, W; Lane, SD; Mohite, S; Ngana, I; Okusaga, OO; Schmitz, JM; Schneider, L; Shah, N; Wu, HE | 1 |
Bechtholt, AJ; Berg, AR; Coyle, JT; Puhl, MD | 1 |
Bosker, WM; Giesbrecht, T; Jan Verkes, R; Kuypers, KP; Merckelbach, H; Ramaekers, JG; Spronk, DB; Theunissen, EL; van Heugten-Van der Kloet, D; van Wel, J | 1 |
Drgonova, J; Johnson, K; Kessler, B; Singhal, S; Troncoso, J; Uhl, GR; Walther, D | 1 |
Labouesse, MA; Langhans, W; Meyer, U | 1 |
Ambrosio, E; Borcel, É; Capellán, R; Higuera-Matas, A; Orihuel, J; Roura-Martínez, D; Santos-Toscano, R; Ucha, M | 1 |
Alvarez, Jdo N; Carvalho, Rde C; Frussa-Filho, R; Fukushiro, DF; Ribeiro, LT; Ricardo, VP | 1 |
Adams, W; Ayton, S; van den Buuse, M | 1 |
Bosch, C; Corvelo, A; Dierssen, M; Maldonado, R; Martín, ED; Martinez, A; Masachs, N; Pujadas, L; Rossi, D; Sahún, I; Soriano, E; Teixeira, CM | 1 |
Bradaia, A; Bruns, A; Buchy, D; Chaboz, S; Galley, G; Groebke Zbinden, K; Hoener, MC; Kilduff, TS; Metzler, V; Morairty, SR; Moreau, JL; Mory, R; Norcross, RD; Pouzet, B; Revel, FG; Risterucci, C; Tuerck, D; Wallace, TL; Wettstein, JG | 1 |
Karlsson, RM; Kircher, DM; O'Donnell, P; Shaham, Y | 1 |
Nishikawa, T | 1 |
ZLATAR, P | 1 |
Bratlid, T; Sjøholm, H; Sundsfjord, J | 1 |
Ebner, N; Fischer, G; Sachs, G; Thau, K; Winklbaur, B | 1 |
Collumbien, EC; Smidt, MH | 1 |
Caine, SB; Fink-Jensen, A; Thomsen, M; Wess, J; Woldbye, DP; Wörtwein, G | 1 |
Ary, AW; Lominac, KD; Szumlinski, KK | 1 |
Monroe, RR | 1 |
MacLennan, AJ; Maier, SF | 1 |
Berger, PA | 1 |
Allen, MH; Alpert, M; Dickson, S; Richardson, NA; Serper, MR; Werner, A | 1 |
Bergström, KA; Hakola, P; Hartikainen, P; Karhu, J; Kuikka, JT; Länsimies, E; Lehtonen, J; Tiihonen, J; Viinamäki, H | 1 |
Eckman, TA; Mintz, J; Roberts, LJ; Shaner, A; Tsuang, JW; Tucker, DE; Wilkins, JN | 2 |
Satel, SL | 1 |
Bowers, MB; Druss, B; Imirowicz, R; Mazure, CM | 1 |
Anthony, D; Charney, DS; Krystal, JH; Satel, SL; Seibyl, JP; Southwick, SM | 1 |
Carroll, K; Rounsaville, B; Schottenfeld, R | 1 |
Beam-Goulet, J; Bell, M; Lysaker, P; Milstein, R | 1 |
Boutros, N; Peabody, C; Rustin, T; Warner, D; Zouridakis, G | 1 |
Debonnel, G | 1 |
Gamble, G; Greenstein, RA; McLellan, AT; Stone, AM | 1 |
Anglin, D; Hsieh, SC; Khalsa, ME; Roberts, L; Shaner, A; Wilkins, J | 1 |
Feldman, J | 1 |
Alpert, M; Serper, MR; Trujillo, M | 1 |
Hameedi, FA; Kosten, TR; Navui, SA; Sernyak, MJ | 1 |
Edwards, H; Egelko, S; Galanter, M; Katz, S | 1 |
Bell, MD; Bioty, SM; Lysaker, PH; Zito, WS | 1 |
Dhopesh, V; Gamble, G; Maany, I; Macfadden, A | 1 |
Bromet, E; Fleischer, J; Jandorf, L; Kovasznay, B; Miller, AD; Tanenberg-Karant, M | 1 |
Kosten, TA | 1 |
Wilkins, JN | 1 |
Eckman, TA; Ho, AP; Shaner, A; Tsuang, JW | 1 |
Yamamoto, J | 1 |
Alim, TN; Collins, JP; Deutsch, SI; Fay-McCarthy, M; Rosse, RB; Wyatt, RJ | 1 |
Innis, RB | 1 |
Caron, MG; Giros, B; Jaber, M; Jones, S | 1 |
Borrelli, E; Chambon, P; Dupé, V; Ghyselinck, N; Kastner, P; Krezel, W; Samad, TA | 1 |
D'Souza, DC; Krystal, JH; Madonick, S; Petrakis, IL | 1 |
Ellison, GD; Geyer, MA; Martinez, ZA; Swerdlow, NR | 1 |
Snyder, SH | 3 |
Alakare, B; Bergman, J; Haaparanta, M; Hietala, J; Laakso, A; Peurasaari, J; Räkköläinen, V; Solin, O; Syvälahti, E; Vilkman, H | 1 |
Bergman, A; Cancro, R; Chou, JC; Copersino, ML; Richarme, D; Serper, MR | 1 |
Abi-Dargham, A; Baldwin, R; D'Souza, DC; Gil, R; Innis, R; Krystal, J; Laruelle, M; Seibyl, J; van Dyck, C | 1 |
Byrnes, JJ; Hammer, RP | 1 |
Fujita, M; Innis, RB; Kugaya, A | 1 |
Farren, CK; Hameedi, FA; Jatlow, P; Kosten, TR; Rosen, MA; Woods, S | 1 |
Cancro, R; Copersino, ML; Richarme, D; Serper, MR; Vadhan, N | 1 |
Abi-Dargham, A; Gelernter, J; Innis, RB; Kegeles, L; Laruelle, M; Martinez, D; van Dyck, CH | 1 |
Bergman, J; Haaparanta, M; Hietala, J; Laakso, A; Solin, O; Syvälahti, E; Vilkman, H | 1 |
Kase, M; Okada, F; Shintomi, Y | 1 |
Post, RM | 1 |
Eberle, F; Hobi, V; Klär, K; Labhardt, F; Ladewig, D; Miest, P; Wyss, P | 1 |
Luchins, D | 1 |
Kosten, T; Lee, E; Petrakis, I; Richardson, T; Ziedonis, D | 1 |
Brenner, L; Charney, DS; Johnson, R; Krystal, JH; Seibyl, JP | 1 |
Hamamura, T; Numachi, Y; Sato, M | 1 |
Eckman, TA; Roberts, LJ; Shaner, A; Tucker, DE; Vaccaro, JV | 1 |
Paredes, A | 1 |
McKenna, AM; Paredes, A | 1 |
Arana, G; Brady, K; Casto, S; Lydiard, RB; Malcolm, R | 1 |
Cole, JO; Gruber, AJ | 1 |
Castaneda, R; Franco, H; Galanter, M; Lifshutz, H | 1 |
Dixon, L; Frances, AJ; Haas, G; Sweeney, J; Weiden, PJ | 1 |
Kinon, BJ; Lieberman, JA; Loebel, AD | 1 |
Bunt, G; Castaneda, R; Galanter, M; Lifshutz, H | 1 |
Kay, SR; Opler, LA; Sevy, S; van Praag, HM | 1 |
Adinoff, B; Anton, R; Ballenger, JC; Brady, K; Lydiard, RB; Selander, J | 1 |
Goodwin, FK | 1 |
Conover, S; Struening, EL; Susser, E | 1 |
Brady, K; Casto, S | 1 |
Langer, SZ; Pimoule, C; Reynolds, GP; Schoemaker, H | 1 |
Alger, I | 1 |
Magoudi, A | 1 |
Lipton, MA | 1 |
Gershon, S; Hekimian, LJ | 1 |
Areal, LB; Herlinger, AL; Martins-Silva, C; Pelição, FS; Pires, RGW | 1 |
Berry, AJ | 1 |
Bebout, RR; Freeman, DW; Harris, M; Hobbs, MD; Kline, JD; Miller, SL; Vanasse, LD | 1 |
McKinnon, K | 1 |
Dermatis, H; Galanter, M; Taubes, T; Westreich, L | 1 |
Bellack, AS; Bennett, ME; Gearon, JS | 1 |
Deutsch, SI; Peace, T; Risher-Flowers, D; Rosse, RB | 1 |
17 review(s) available for cocaine and Schizophrenia
Article | Year |
---|---|
Moonlighting proteins and protein-protein interactions as neurotherapeutic targets in the G protein-coupled receptor field.
Topics: Animals; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Cocaine; Cocaine-Related Disorders; Depression; Drug Discovery; Humans; Molecular Targeted Therapy; Parkinson Disease; Protein Interaction Mapping; Receptors, G-Protein-Coupled; Schizophrenia | 2014 |
[Genetic study on schizophrenia and its recurrence utilizing pharmacological models].
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Cocaine; Disease Models, Animal; Dopamine Agents; Humans; Ketamine; Phencyclidine; Receptors, N-Methyl-D-Aspartate; Recurrence; Schizophrenia | 2002 |
Substance abuse in patients with schizophrenia.
Topics: Cannabis; Cocaine; Humans; Nicotine; Schizophrenia; Substance-Related Disorders | 2006 |
Homers regulate drug-induced neuroplasticity: implications for addiction.
Topics: Animals; Carrier Proteins; Cocaine; Ethanol; Glutamic Acid; Homer Scaffolding Proteins; Humans; Methamphetamine; Neuronal Plasticity; Nucleus Accumbens; Prefrontal Cortex; Schizophrenia; Substance-Related Disorders | 2008 |
Biochemistry and the schizophrenia. Old concepts and new hypothesis.
Topics: Acetylcholine; Amphetamine; Animals; Brain; Cocaine; Dopamine; Endorphins; gamma-Aminobutyric Acid; Humans; Methylphenidate; Naloxone; Norepinephrine; Phenethylamines; Physostigmine; Schizophrenia; Schizophrenia, Paranoid | 1981 |
Comorbid psychiatric disorders and cocaine abuse.
Topics: Cocaine; Humans; Mental Disorders; Schizophrenia; Substance-Related Disorders | 1993 |
Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry.
Topics: Binding Sites; Cocaine; Female; Glutamates; Hippocampus; Humans; Ligands; Male; Neuropeptide Y; Psychiatry; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Schizophrenia | 1993 |
The dopamine transporter: a crucial component regulating dopamine transmission.
Topics: Amphetamines; Animals; Brain; Carrier Proteins; Central Nervous System Stimulants; Cocaine; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Gene Dosage; Genotype; Homeostasis; Humans; Hyperkinesis; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Knockout; Mice, Transgenic; Nerve Tissue Proteins; Parkinson Disease; Phenotype; Rats; Schizophrenia; Substance-Related Disorders | 1997 |
Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Cannabis; Central Nervous System Stimulants; Cocaine; Cognition Disorders; Dopamine; Health Care Costs; Humans; Nicotine; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1999 |
Drugs for a new millennium.
Topics: Animals; Antipsychotic Agents; Apoptosis; Cocaine; Drug Design; Illicit Drugs; Myocardial Infarction; Proto-Oncogene Proteins c-bcl-2; Schizophrenia; Stroke | 1999 |
Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders.
Topics: Animals; Benzamides; Brain; Carrier Proteins; Cocaine; Disease Progression; Dopamine Plasma Membrane Transport Proteins; Humans; Iodine Radioisotopes; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Schizophrenia; Synaptic Transmission; Tomography, Emission-Computed, Single-Photon | 2000 |
Relapse of paranoid psychotic state in methamphetamine model of schizophrenia.
Topics: Animals; Cocaine; Cross-Sectional Studies; Dopamine; Female; Humans; Japan; Male; Methamphetamine; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology; Terminology as Topic | 1992 |
Dual-diagnosis empirical and developmental-humanistic approaches.
Topics: Alcoholism; Cocaine; Combined Modality Therapy; Comorbidity; Cross-Sectional Studies; Humans; Incidence; Schizophrenia; Schizophrenic Psychology; Self Concept; Substance-Related Disorders; United States | 1992 |
Antidepressant effects of flupenthixol.
Topics: Affect; Antidepressive Agents; Cocaine; Depressive Disorder; Flupenthixol; Humans; Schizophrenia; Substance-Related Disorders | 1991 |
Dopaminergic mechanisms in idiopathic and drug-induced psychoses.
Topics: Amphetamine; Animals; Brain; Cocaine; Dopamine; Dose-Response Relationship, Drug; Humans; Psychoses, Substance-Induced; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1990 |
[Critical review of the analytic literature on drug addiction].
Topics: Adolescent; Alcoholism; Borderline Personality Disorder; Cocaine; Freudian Theory; Humans; Juvenile Delinquency; Male; Personality Disorders; Psychoanalytic Interpretation; Schizophrenia; Substance-Related Disorders | 1985 |
Catecholamines in the brain as mediators of amphetamine psychosis.
Topics: Amphetamine; Animals; Antidepressive Agents; Brain Chemistry; Bromides; Catecholamines; Cats; Cocaine; Compulsive Behavior; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Hallucinogens; Humans; Isomerism; Monoamine Oxidase Inhibitors; Norepinephrine; Pan troglodytes; Paranoid Disorders; Phenothiazines; Psychoses, Alcoholic; Psychoses, Substance-Induced; Rats; Receptors, Drug; Schizophrenia; Substance-Related Disorders; Synaptic Transmission | 1972 |
3 trial(s) available for cocaine and Schizophrenia
Article | Year |
---|---|
MDMA, cannabis, and cocaine produce acute dissociative symptoms.
Topics: Adult; Amphetamine-Related Disorders; Cannabinoids; Cocaine; Cocaine-Related Disorders; Cross-Over Studies; Dissociative Disorders; Double-Blind Method; Female; Humans; Male; Marijuana Abuse; N-Methyl-3,4-methylenedioxyamphetamine; Schizophrenia; Surveys and Questionnaires | 2015 |
Significant interaction between clozapine and cocaine in cocaine addicts.
Topics: Adult; Arousal; Clozapine; Cocaine; Cocaine-Related Disorders; Comorbidity; Dose-Response Relationship, Drug; Drug Interactions; Euphoria; Humans; Male; Risk Factors; Schizophrenia; Syncope | 2000 |
Antidepressant effects of flupenthixol.
Topics: Affect; Antidepressive Agents; Cocaine; Depressive Disorder; Flupenthixol; Humans; Schizophrenia; Substance-Related Disorders | 1991 |
88 other study(ies) available for cocaine and Schizophrenia
Article | Year |
---|---|
[Rhabdomyolysis associated with cocaine abuse in a patient with schizophrenia].
Topics: Adult; Cocaine; Cocaine-Related Disorders; Humans; Male; Psychotropic Drugs; Rhabdomyolysis; Schizophrenia | 2022 |
Impaired extinction of operant cocaine in a genetic mouse model of schizophrenia risk.
Topics: Animals; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Cues; Extinction, Psychological; Male; Mice; Reinforcement, Psychology; Schizophrenia; Self Administration; Sucrose | 2023 |
Associations of comorbid substance use disorders with clinical outcomes in schizophrenia using electronic health record data.
Topics: Antipsychotic Agents; Cannabis; Cocaine; Cocaine-Related Disorders; Comorbidity; Electronic Health Records; Humans; Schizophrenia; Substance-Related Disorders | 2023 |
Maternal immune activation is associated with a lower number of dopamine receptor 3-expressing granulocytes with no alterations in cocaine reward, resistance to extinction or cue-induced reinstatement.
Topics: Animals; Biomarkers; Cells, Cultured; Cocaine; Cocaine-Related Disorders; Cues; Disease Models, Animal; Drug-Seeking Behavior; Extinction, Psychological; Female; Granulocytes; Leukocyte Count; Lipopolysaccharides; Male; Pregnancy; Prepulse Inhibition; Rats; Rats, Inbred Lew; Receptor, Cannabinoid, CB2; Receptors, Dopamine D3; Reward; Schizophrenia; Self Administration; T-Lymphocytes | 2020 |
Risk-taking and fairness among cocaine-dependent patients in dual diagnoses: Schizophrenia and Anti-Social Personality Disorder.
Topics: Affect; Antisocial Personality Disorder; Cocaine; Cocaine-Related Disorders; Comorbidity; Decision Making; Diagnosis, Dual (Psychiatry); Female; Games, Experimental; Humans; Male; Personality Disorders; Risk-Taking; Schizophrenia; Schizophrenic Psychology; Social Behavior | 2020 |
Orbitofrontal sulcogyral morphology in patients with cocaine use disorder.
Topics: Cocaine; Humans; Magnetic Resonance Imaging; Male; Prefrontal Cortex; Schizophrenia; Substance-Related Disorders | 2020 |
Effects of JL13, a pyridobenzoxazepine compound, in dopaminergic and glutamatergic models of antipsychotic activity.
Topics: Animals; Antipsychotic Agents; Cocaine; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Glutamic Acid; Ketamine; Locomotion; Male; Mice; Oxazepines; Piperazines; Pyridines; Reflex, Startle; Schizophrenia | 2021 |
N-Methyl-d-aspartate receptor co-agonist availability affects behavioral and neurochemical responses to cocaine: insights into comorbid schizophrenia and substance abuse.
Topics: Animals; Cocaine; Comorbidity; Dopamine; Dopamine Uptake Inhibitors; gamma-Aminobutyric Acid; Glutamic Acid; Mice; Mice, Knockout; Microdialysis; Nucleus Accumbens; Racemases and Epimerases; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Self Stimulation; Serine; Substance-Related Disorders | 2019 |
Effects of the monoamine stabilizer (-)-OSU6162 on locomotor and sensorimotor responses predictive of antipsychotic activity.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Cocaine; Dopamine Uptake Inhibitors; Excitatory Amino Acid Antagonists; Ketamine; Locomotion; Male; Mice; Piperidines; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Schizophrenia | 2018 |
Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls.
Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamines; Central Nervous System Stimulants; Cocaine; Cognition Disorders; Comorbidity; Cross-Sectional Studies; Dopamine Uptake Inhibitors; Female; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Psychotic Disorders; Schizophrenia; Siblings; Young Adult | 2014 |
Hospital length of stay in individuals with schizophrenia with and without cocaine-positive urine drug screens at hospital admission.
Topics: Adult; Cocaine; Cocaine-Related Disorders; Comorbidity; Female; Humans; Length of Stay; Male; Middle Aged; Patient Admission; Schizophrenia; Substance Abuse Detection | 2015 |
Availability of N-Methyl-d-Aspartate Receptor Coagonists Affects Cocaine-Induced Conditioned Place Preference and Locomotor Sensitization: Implications for Comorbid Schizophrenia and Substance Abuse.
Topics: Animals; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Gene Knockdown Techniques; Glycine Plasma Membrane Transport Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Racemases and Epimerases; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Substance-Related Disorders | 2015 |
Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models.
Topics: Animals; Cocaine; Cocaine-Related Disorders; Cognition; Conditioning, Psychological; Female; Gene Expression Regulation; Gene Knockout Techniques; Genetic Loci; Humans; Locomotion; Male; Maze Learning; Membrane Proteins; Memory; Mice; Phenotype; Polymorphism, Single Nucleotide; Schizophrenia; Spatial Behavior; Tumor Suppressor Proteins | 2015 |
Abnormal context-reward associations in an immune-mediated neurodevelopmental mouse model with relevance to schizophrenia.
Topics: Animals; Cocaine; Conditioning, Psychological; Disease Models, Animal; Fear; Female; Mice; Mice, Inbred C57BL; Neurodevelopmental Disorders; Poly I-C; Pregnancy; Prenatal Exposure Delayed Effects; Reward; Schizophrenia; Sucrose | 2015 |
Unaltered cocaine self-administration in the prenatal LPS rat model of schizophrenia.
Topics: Animals; Auditory Perception; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dopamine Uptake Inhibitors; Female; Lipopolysaccharides; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Pregnancy; Prenatal Exposure Delayed Effects; Prepulse Inhibition; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Self Administration; Sex Characteristics | 2016 |
Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Cocaine; Cocaine-Related Disorders; Haloperidol; Humans; Male; Mice; Motor Activity; Piperazines; Schizophrenia; Substance Withdrawal Syndrome; Thiazoles | 2008 |
Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophrenia.
Topics: 5,7-Dihydroxytryptamine; Amphetamines; Animals; Cocaine; Disease Models, Animal; Dose-Response Relationship, Drug; Hippocampus; Hyperkinesis; Ketamine; Male; Phencyclidine; Rats; Rats, Sprague-Dawley; Schizophrenia; Serotonin | 2009 |
Overexpression of Reelin prevents the manifestation of behavioral phenotypes related to schizophrenia and bipolar disorder.
Topics: Animals; Bipolar Disorder; Cell Adhesion Molecules, Neuronal; Cocaine; Corticosterone; Exploratory Behavior; Extracellular Matrix Proteins; Female; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Mice, Transgenic; Nerve Tissue Proteins; Phenotype; Reelin Protein; Schizophrenia; Sensory Gating; Serine Endopeptidases | 2011 |
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Attention; Benzodiazepines; Body Weight; Cocaine; Conditioning, Operant; Depression; Disease Models, Animal; Dopamine Uptake Inhibitors; Electroencephalography; Hallucinogens; Haloperidol; Humans; Macaca fascicularis; Magnetic Resonance Imaging; Male; Mental Recall; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microinjections; Motor Activity; Mutation; Olanzapine; Oocytes; Oxazoles; Phencyclidine; Phenethylamines; Protein Binding; Pyrrolidinones; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reinforcement, Psychology; Schizophrenia; Swimming; Telemetry; Tritium; Xenopus | 2013 |
Exaggerated cue-induced reinstatement of cocaine seeking but not incubation of cocaine craving in a developmental rat model of schizophrenia.
Topics: Animals; Animals, Newborn; Brain Mapping; Cocaine; Cocaine-Related Disorders; Cues; Diagnosis, Dual (Psychiatry); Disease Models, Animal; Drug-Seeking Behavior; Extinction, Psychological; Female; Hippocampus; Rats; Rats, Long-Evans; Schizophrenia; Schizophrenic Psychology; Self Administration; Substance Withdrawal Syndrome | 2013 |
[A CASE OF BLENNORRHAGIC IRIDOCYCLITIS IN A SCHIZOPHRENIC].
Topics: Arthritis; Atropine; Cocaine; Drug Therapy; Epinephrine; Gonorrhea; Humans; Iridocyclitis; Penicillins; Schizophrenia; Urethritis | 1964 |
123I-beta-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia.
Topics: Adult; Basal Ganglia; Binding Sites; Brain Mapping; Cocaine; Dopamine Plasma Membrane Transport Proteins; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Presynaptic Terminals; Radiopharmaceuticals; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 2004 |
[A cocaine-induced variant of the neuroleptic malignant syndrome. A case study].
Topics: Bromocriptine; Cocaine; Dantrolene; Dopamine Agonists; Humans; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Schizophrenia; Treatment Outcome | 2006 |
Decreased prepulse inhibition and increased sensitivity to muscarinic, but not dopaminergic drugs in M5 muscarinic acetylcholine receptor knockout mice.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Cocaine; Dextroamphetamine; Dopamine Agonists; Female; Genotype; Haloperidol; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Muscarinic Agonists; Receptors, Muscarinic; Reflex; Reflex, Startle; Schizophrenia; Trihexyphenidyl | 2007 |
Limbic ictus and atypical psychoses.
Topics: Amphetamine; Animals; Carbamazepine; Cocaine; Electric Stimulation; Electroencephalography; Epilepsy; Humans; Kindling, Neurologic; Limbic System; Models, Neurological; Psychotic Disorders; Schizophrenia; Synaptic Transmission | 1982 |
Coping and the stress-induced potentiation of stimulant stereotypy in the rat.
Topics: Animals; Cocaine; Dextroamphetamine; Disease Models, Animal; Drug Synergism; Humans; Rats; Schizophrenia; Stereotyped Behavior; Stress, Physiological | 1983 |
Clinical effects of recent cocaine use on patients with acute schizophrenia.
Topics: Acute Disease; Adult; Affect; Central Nervous System Stimulants; Cocaine; Comorbidity; Diagnosis, Dual (Psychiatry); Emergency Services, Psychiatric; Female; Follow-Up Studies; Hospitalization; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Self Medication; Severity of Illness Index; Substance-Related Disorders | 1995 |
Imaging of serotonin and dopamine transporters in the living human brain.
Topics: Adult; Brain; Brain Chemistry; Carrier Proteins; Cocaine; Depressive Disorder; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Panic Disorder; Parkinson Disease; Schizophrenia; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tomography, Emission-Computed, Single-Photon | 1995 |
Disability income, cocaine use, and repeated hospitalization among schizophrenic cocaine abusers--a government-sponsored revolving door?
Topics: Adult; Cocaine; Hospitalization; Hospitals, Psychiatric; Humans; Ill-Housed Persons; Male; Periodicity; Schizophrenia; Social Security; Substance-Related Disorders; United States; Veterans Disability Claims | 1995 |
When disability benefits make patients sicker.
Topics: Cocaine; Financing, Government; Humans; Schizophrenia; Social Security; Substance-Related Disorders; United States; Veterans Disability Claims | 1995 |
Autonomous psychosis following psychotogenic substance abuse.
Topics: Cocaine; Dronabinol; Female; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Psychoses, Substance-Induced; Psychotropic Drugs; Recurrence; Risk Factors; Schizophrenia | 1995 |
Effects of cocaine on hospital course in schizophrenia.
Topics: Adult; Antipsychotic Agents; Cocaine; Cohort Studies; Employment; Hospital Records; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Substance-Related Disorders; Suicide | 1993 |
Relationship of positive and negative symptoms to cocaine abuse in schizophrenia.
Topics: Analysis of Variance; Cocaine; Comorbidity; Humans; Prevalence; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Severity of Illness Index; Substance-Related Disorders | 1994 |
The P50 component of the auditory evoked potential and subtypes of schizophrenia.
Topics: Acoustic Stimulation; Adolescent; Adult; Attention; Cerebral Cortex; Cocaine; Evoked Potentials, Auditory; Female; Humans; Male; Reaction Time; Reference Values; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Substance-Related Disorders | 1993 |
Cocaine use by schizophrenic outpatients who receive depot neuroleptic medication.
Topics: Adult; Ambulatory Care; Chronic Disease; Cocaine; Combined Modality Therapy; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Middle Aged; Schizophrenia; Schizophrenic Psychology; Substance Abuse Detection; Substance-Related Disorders; Veterans | 1993 |
Unrecognized cocaine use among schizophrenic patients.
Topics: Adult; Age Factors; Black or African American; Cocaine; Female; Hospitalization; Humans; Ill-Housed Persons; Male; Middle Aged; Prognosis; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Substance Abuse Detection; Substance-Related Disorders; Unemployment | 1993 |
Disability payments among schizophrenic cocaine abusers.
Topics: Cocaine; Financing, Government; Humans; Male; Schizophrenia; Substance-Related Disorders; United States | 1996 |
Recent cocaine use decreases negative signs in acute schizophrenia: a case study over two consecutive admissions.
Topics: Acute Disease; Affect; Arousal; Cocaine; Comorbidity; Crack Cocaine; Depression; Female; Humans; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Self Medication; Substance-Related Disorders | 1996 |
Near syncope associated with concomitant clozapine and cocaine use.
Topics: Administration, Intranasal; Adult; Blood Pressure; Clozapine; Cocaine; Drug Interactions; Heart Rate; Humans; Male; Schizophrenia; Substance-Related Disorders; Syncope | 1996 |
Can cocaine addicts with severe mental illness be treated along with singly diagnosed addicts?
Topics: Adult; Cocaine; Diagnosis, Dual (Psychiatry); Female; Humans; Ill-Housed Persons; Male; Mood Disorders; Motivation; New York City; Patient Compliance; Schizophrenia; Substance Abuse Treatment Centers; Substance-Related Disorders; Treatment Outcome | 1996 |
Cognitive impairment and substance abuse history as predictors of the temporal stability of negative symptoms in schizophrenia.
Topics: Adult; Age Factors; Amphetamine; Cocaine; Cognition Disorders; Comorbidity; Diagnosis, Dual (Psychiatry); Female; Follow-Up Studies; Humans; Male; Neuropsychological Tests; Probability; Regression Analysis; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Substance-Related Disorders | 1997 |
Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Cocaine; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Neurologic Examination; Opioid-Related Disorders; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Schizophrenia | 1997 |
Substance use disorder and the early course of illness in schizophrenia and affective psychosis.
Topics: Adult; Affective Disorders, Psychotic; Alcohol Drinking; Cocaine; Female; Humans; Male; Marijuana Abuse; Schizophrenia; Substance-Related Disorders | 1997 |
Enhanced neurobehavioral effects of cocaine with chronic neuroleptic exposure in rats.
Topics: Animals; Antipsychotic Agents; Cocaine; Discrimination, Psychological; Dopamine; Dopamine Antagonists; Drug Synergism; Haloperidol; Humans; Motor Activity; Rats; Schizophrenia; Stereotyped Behavior; Substance-Related Disorders | 1997 |
Pharmacotherapy of schizophrenia patients with comorbid substance abuse.
Topics: Alcoholism; Antipsychotic Agents; Cocaine; Flupenthixol; Humans; Imipramine; Marijuana Abuse; Opioid-Related Disorders; Schizophrenia; Self Medication; Substance-Related Disorders; Tobacco Use Disorder | 1997 |
Monetary reinforcement of abstinence from cocaine among mentally ill patients with cocaine dependence.
Topics: Adult; Behavior Therapy; Cocaine; Diagnosis, Dual (Psychiatry); Follow-Up Studies; Humans; Ill-Housed Persons; Male; Motivation; Reinforcement, Psychology; Schizophrenia; Substance Abuse Detection; Substance-Related Disorders; Treatment Outcome | 1997 |
Dual diagnosis treatment for patients with schizophrenia who are substance dependent.
Topics: Adult; Ambulatory Care; Case Management; Cocaine; Diagnosis, Dual (Psychiatry); Hospitals, Veterans; Humans; Los Angeles; Psychotherapy; Residential Treatment; Schizophrenia; Substance-Related Disorders; Treatment Outcome | 1997 |
Cortical and hippocampal EEG power spectra in animal models of schizophrenia produced with methamphetamine, cocaine, and phencyclidine.
Topics: Adrenergic Agents; Animals; Cerebral Cortex; Cocaine; Disease Models, Animal; Electroencephalography; Hallucinogens; Hippocampus; Male; Methamphetamine; Phencyclidine; Rabbits; Schizophrenia | 1997 |
Phenomenologic comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychoses: a retrospective study.
Topics: Adult; Cocaine; Hallucinogens; Humans; Male; Narcotics; Phencyclidine; Psychoses, Substance-Induced; Psychotic Disorders; Retrospective Studies; Schizophrenia; Substance-Related Disorders | 1994 |
Single photon emission computed tomography imaging of dopaminergic function: presynaptic transporter, postsynaptic receptor, and "intrasynaptic" transmitter.
Topics: Animals; Benzamides; Brain; Carrier Proteins; Cocaine; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Humans; Iodine Radioisotopes; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Parkinson Disease; Presynaptic Terminals; Primates; Pyrrolidines; Receptors, Dopamine; Reference Values; Schizophrenia; Serotonin; Serotonin Plasma Membrane Transport Proteins; Synapses; Tomography, Emission-Computed, Single-Photon | 1998 |
Impaired locomotion and dopamine signaling in retinoid receptor mutant mice.
Topics: Animals; Cocaine; Corpus Striatum; Dimerization; Dopamine; Locomotion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Muscle, Skeletal; Parkinson Disease; Peripheral Nervous System; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Retinoic Acid; Retinoid X Receptors; Schizophrenia; Signal Transduction; Transcription Factors | 1998 |
Effects of sustained cocaine exposure on sensorimotor gating of startle in rats.
Topics: Acoustic Stimulation; Animals; Brain; Cocaine; Dopamine Uptake Inhibitors; Female; Habituation, Psychophysiologic; Motor Activity; Observation; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia | 1999 |
Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography.
Topics: Adult; Antipsychotic Agents; Brain; Carrier Proteins; Caudate Nucleus; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Functional Laterality; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Schizophrenia; Tomography, Emission-Computed | 2000 |
Learning and memory impairment in cocaine-dependent and comorbid schizophrenic patients.
Topics: Acute Disease; Adult; Analysis of Variance; Cocaine; Cocaine-Related Disorders; Cognition; Diagnosis, Dual (Psychiatry); Female; Humans; Male; Memory; Mental Recall; Schizophrenia; Schizophrenic Psychology; Verbal Learning | 2000 |
Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.
Topics: Adult; Age Factors; Brain Stem; Carrier Proteins; Case-Control Studies; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Neostriatum; Nerve Tissue Proteins; Schizophrenia; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tomography, Emission-Computed, Single-Photon | 2000 |
The disruptive effect of cocaine on prepulse inhibition is prevented by repeated administration in rats.
Topics: Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Cocaine; Dopamine Uptake Inhibitors; Drug Administration Schedule; Inhibition, Psychological; Male; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia | 2000 |
Neurocognitive functioning in recently abstinent, cocaine-abusing schizophrenic patients.
Topics: Adult; Attention; Cocaine; Cocaine-Related Disorders; Female; Humans; Male; Mental Recall; Middle Aged; Neuropsychological Tests; Psychometrics; Schizophrenia; Schizophrenic Psychology; Serial Learning; Substance Withdrawal Syndrome; Verbal Learning | 2000 |
The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans.
Topics: Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Benzamides; Carrier Proteins; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Genotype; Humans; Iodine Radioisotopes; Membrane Glycoproteins; Membrane Transport Proteins; Minisatellite Repeats; Neostriatum; Nerve Tissue Proteins; Phenotype; Polymorphism, Genetic; Psychotic Disorders; Pyrrolidines; Radiopharmaceuticals; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 2001 |
Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia.
Topics: Adult; Brain Mapping; Chronic Disease; Cocaine; Corpus Striatum; Dominance, Cerebral; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Psychiatric Status Rating Scales; Radioligand Assay; Schizophrenia; Tomography, Emission-Computed | 2001 |
Pupillary abnormalities in schizophrenic patients during long-term administration of psychotropic drugs: dissociation between light and near vision reactions.
Topics: Adult; Cocaine; Epinephrine; Female; Humans; Male; Methacholine Compounds; Middle Aged; Photic Stimulation; Psychotropic Drugs; Pupil; Schizophrenia; Tyramine; Vision, Ocular | 1978 |
Biochemical factors in Schizophrenia.
Topics: Amphetamines; Animals; Binding Sites; Brain; Cocaine; Dopamine; Humans; Levodopa; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Receptors, Dopamine; Schizophrenia; Tranquilizing Agents | 1977 |
Cocaine psychoses: a continuum model.
Topics: Aggression; Animals; Anxiety; Bipolar Disorder; Blood Pressure; Cocaine; Delusions; Depression; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Euphoria; Hallucinations; Humans; Psychoses, Substance-Induced; Pulse; Schizophrenia; Stress, Psychological; Substance-Related Disorders | 1975 |
[Schizophreniform conditions in adolescent drug users differentiation possibilities using objective personality inventories].
Topics: Adolescent; Adult; Amphetamines; Cannabis; Cocaine; Diagnosis, Differential; Female; Humans; Longitudinal Studies; Lysergic Acid Diethylamide; Male; Mental Disorders; Personality Inventory; Prognosis; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Schizophrenia; Statistics as Topic; Substance-Related Disorders | 1975 |
The dopamine hypothesis of schizophrenia. A critical analysis.
Topics: Acetylcholine; Amphetamine; Apomorphine; Cocaine; Dopamine; Electroconvulsive Therapy; gamma-Aminobutyric Acid; Humans; Levodopa; Methyldopa; Methyltyrosines; Models, Neurological; Psychoses, Substance-Induced; Schizophrenia; Tranquilizing Agents | 1975 |
Adjunctive desipramine in the treatment of cocaine abusing schizophrenics.
Topics: Adult; Cocaine; Desipramine; Female; Humans; Male; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1992 |
Mazindol and cocaine addiction in schizophrenia.
Topics: Adult; Cocaine; Humans; Male; Mazindol; Schizophrenia; Substance-Related Disorders | 1992 |
Effectively treating stimulant-abusing schizophrenics: mission impossible?
Topics: Adult; Amphetamines; Cocaine; Combined Modality Therapy; Humans; Male; Managed Care Programs; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1992 |
Clinical pathology. Overview.
Topics: Alcoholism; Cocaine; Comorbidity; Humans; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1992 |
Substance abuse in an inpatient psychiatric sample.
Topics: Adult; Alcoholism; Bipolar Disorder; Cocaine; Cross-Sectional Studies; Depressive Disorder; Female; Hospitalization; Humans; Incidence; Male; Mental Disorders; Psychiatric Department, Hospital; Psychotropic Drugs; Risk Factors; Schizophrenia; Schizophrenic Psychology; South Carolina; Stress Disorders, Post-Traumatic; Substance-Related Disorders | 1991 |
Effect of drugs of abuse on psychiatric symptoms among hospitalized schizophrenics.
Topics: Adult; Alcoholism; Cocaine; Crack Cocaine; Female; Humans; Illicit Drugs; Male; Personality Inventory; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1991 |
Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
Topics: Adolescent; Adult; Alcoholism; Cocaine; Female; Hospitalization; Humans; Male; Marijuana Abuse; Middle Aged; Motivation; Prevalence; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1991 |
Cocaine/"crack" dependence among psychiatric inpatients.
Topics: Adolescent; Adult; Cocaine; Comorbidity; Female; Hospitalization; Humans; Male; Mental Disorders; New York City; Personality Disorders; Schizophrenia; Substance-Related Disorders | 1990 |
Significance of cocaine history in schizophrenia.
Topics: Adult; Cocaine; Cognition Disorders; Depressive Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychological Tests; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1990 |
Cocaine abuse among schizophrenic patients.
Topics: Adult; Cocaine; Depressive Disorder; Hospitalization; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Substance-Related Disorders | 1990 |
From the Alcohol, Drug Abuse, and Mental Health Administration.
Topics: Animals; Antipsychotic Agents; Buprenorphine; Cocaine; Female; Heroin; Humans; Macaca mulatta; Male; Obsessive-Compulsive Disorder; Schizophrenia; Substance-Related Disorders; Trichotillomania | 1989 |
Psychiatric problems in homeless men. Lifetime psychosis, substance use, and current distress in new arrivals at New York City shelters.
Topics: Adolescent; Adult; Age Factors; Alcoholism; Cocaine; Humans; Ill-Housed Persons; Male; Mental Disorders; Middle Aged; New York City; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Substance-Related Disorders; Suicide | 1989 |
Illicit substance use by acutely psychotic patients.
Topics: Acute Disease; Cocaine; Humans; Psychotic Disorders; Schizophrenia; Substance-Related Disorders | 1989 |
[3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease.
Topics: Aged; Antipsychotic Agents; Benzazepines; Cocaine; Humans; In Vitro Techniques; Middle Aged; Parkinson Disease; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D1; Schizophrenia; Spiperone | 1985 |
Major mental health issues: schizophrenia, cocaine abuse.
Topics: Cocaine; Family Therapy; Health Education; Humans; Schizophrenia; Substance-Related Disorders; Videotape Recording | 1986 |
Neuropsychopharmacology of monoamines and their regulatory enzymes.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Apomorphine; Biogenic Amines; Brain; Cocaine; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Dopamine beta-Hydroxylase; Humans; Isoenzymes; Methylphenidate; Monoamine Oxidase; Neurons; Norepinephrine; Phenylethanolamine N-Methyltransferase; Schizophrenia; Serotonin; Tyrosine; Tyrosine 3-Monooxygenase | 1974 |
Characteristics of drug abusers admitted to a psychiatric hospital.
Topics: Adult; Age Factors; Amphetamine; Antisocial Personality Disorder; Antitussive Agents; Barbiturates; Cannabis; Cocaine; Crime; Depression; Euphoria; Female; Glutethimide; Hallucinogens; Hospitalization; Hospitals, Psychiatric; Humans; Lysergic Acid Diethylamide; Male; Mental Disorders; Morphine Dependence; Motivation; Personality Disorders; Schizophrenia; Sex Factors; Substance-Related Disorders; Trichloroethylene | 1968 |
Crack cocaine inhalation induces schizophrenia-like symptoms and molecular alterations in mice prefrontal cortex.
Topics: Animals; Crack Cocaine; Disease Models, Animal; Gene Expression Regulation; Interpersonal Relations; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Mice; Mice, Inbred C57BL; Prefrontal Cortex; Protein Isoforms; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Schizophrenic Psychology | 2017 |
Acute dyskinesia in a patient with schizophrenia.
Topics: Adult; Antipsychotic Agents; Clozapine; Cocaine-Related Disorders; Crack Cocaine; Dyskinesia, Drug-Induced; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Schizophrenia; Substance Withdrawal Syndrome; Treatment Outcome | 2018 |
Work stories: psychological responses to work in a population of dually diagnosed adults.
Topics: Adult; Alcoholism; Crack Cocaine; Diagnosis, Dual (Psychiatry); Female; Focus Groups; Humans; Male; Managed Care Programs; Mental Disorders; Middle Aged; Patient Care Team; Psychotic Disorders; Rehabilitation, Vocational; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders; Urban Population; Vocational Guidance | 1997 |
HIV risk behaviors.
Topics: Alcoholism; Crack Cocaine; Female; HIV Infections; Homosexuality; Humans; Male; Mental Disorders; Psychiatric Status Rating Scales; Risk-Taking; Schizophrenia; Schizophrenic Psychology; Sexual Partners; Substance-Related Disorders | 1997 |
Crack cocaine and schizophrenia as risk factors for PPD reactivity in the dually diagnosed.
Topics: Adolescent; Adult; Cocaine-Related Disorders; Comorbidity; Crack Cocaine; Diagnosis, Dual (Psychiatry); Female; Humans; Male; Middle Aged; New York City; Risk; Risk Factors; Schizophrenia; Tuberculin Test; Tuberculosis, Pulmonary; Urban Population | 1998 |
Treating substance abuse in schizophrenia. An initial report.
Topics: Adolescent; Adult; Alcoholism; Behavior Therapy; Cocaine-Related Disorders; Combined Modality Therapy; Comorbidity; Crack Cocaine; Diagnosis, Dual (Psychiatry); Female; Heroin Dependence; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Patient Dropouts; Role Playing; Schizophrenia; Schizophrenic Psychology; Substance Abuse Detection | 2001 |
Evidence of impaired smooth pursuit eye movement performance in crack cocaine users.
Topics: Adult; Basal Ganglia; Cerebral Cortex; Chronic Disease; Crack Cocaine; Humans; Male; Pursuit, Smooth; Reference Values; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1992 |